Skip to main content

Pharmacology Articles

pharma courses

  • H2S : REVOLUTIONARY SCIENTIFIC MIRACLE AS A GASOTRANSMITTER AT MAXIMUM POTENTIAL IF USED WISELY

    ABOUT AUTHORS:
    Krishna J. Kathawala1*, Gaurav L. Ninama1, Ankitkumar Y. Parikh1, Krupali V. Upadhyay2
    1A. R. College of Pharmacy & G. H. Patel Institute of Pharmacy B/H. B & B Polytechnic College, Vallabh Vidyanagar - 388 120, Gujarat, India.
    2Shree Satsangi Saketdham “Ram Ashram” group of Institution, At. & Post. Vadasma, Tal. & Dist. Mehsana, Gujarat – 382708, India.
    *krishna.kathawala@gmail.com

    ABSTRACT
    Nitric oxide (NO) and Carbon monoxide (CO) are the reputed neurotransmitters involved in the regulation of vascular tone. H2S, which synthesized from L-cysteine, can play more vital role as Gasotransmitters compare to NO and CO. H2S have a role as a stimulator of ATP-sensitive potassium channels (KATP-channels) in the vascular smooth muscle cells, neurons, cardiomyocytes and pancreatic β-cells. H2S also minimize the toxic effect by reacting with reactive oxygen and/or nitrogen species and attenuating their physiological functions. H2S have a unique feature of not to stimulate soluble guanylate-cyclase like other Gasotransmitters. H2S plays a critical role in the regulation of vascular tone, neurotransmission, insulin secretion, and myocardial contractility. Recent studies showed that, in various animal models of arterial and pulmonary hypertension, Alzheimer’s disease, gastric mucosal injury and liver cirrhosis had H2S deficiency which defines the significance of H2S. Exogenous H2S alleviates myocardial dysfunction associated with the ischemia/reperfusion injury with reducing the damage of gastric mucosa generated by anti-inflammatory drugs. H2S had also some drawbacks like every coin has two sides. Excessive production of H2S may contribute to the pathogenesis of inflammatory diseases, septic shock, cerebral stroke and mental retardation in patients with Down syndrome, and reduction of its production may be of potential therapeutic value in these states. Preclinical evidence is provided to show that H2S releasing derivatives of several NSAIDs, including Diclofenac and Indomethacin indeed represent excellent gastrointestinal safety and are more potent than the parent drugs as anti inflammatory agents. Derivatives of anti-inflammatory drugs other than NSAIDs (e.g. mesalamine) have also been shown to be significantly improved over the parent drug in many respects. So, H2S can be Revolutionary scientific miracle as a gasotransmitters  at maximum potential if the drawbacks are minimize by cutting edge solution.

  • AN OVERVIEW ON PHARMACOVIGILANCE

    ABOUT AUTHORS:
    Jain Deepika*, Rathore Kamal Singh
    BN Institute of Pharmaceutical Sciences,
    Udaipur-Raj.313002 INDIA
    *dpka88jain@gmail.com

    ABSTRACT
    Pharmacovigilance is particularly concerned with adverse drug reactions, or ADRs, which are officially described as: “A response to a drug which is noxious and unintended, and which occurs at doses normally used for the prophylaxis, diagnosis or therapy of disease, or for the modification of physiological function”. The mission of Pharmacovigilance is to contribute to the protection of public health in the regulation of the safety; quality and efficacy of medicines for human use and to ensure the healthcare professionals and patients have access to information about the safe and effective use of medicine. The World Health Organization (WHO) defines an adverse drug reaction (ADR) as “Any response to a drug which is noxious and unintended, and which occurs at doses normally used in man for prophylaxis, diagnosis or therapy of disease or for modification of the physiological function”.

    The discipline of pharmacovigilance has developed considerably since the 1972 WHO technical report, and it remains a dynamic clinical and scientific discipline. It has been essential to meet the challenges of the increasing range and potency of medicines (including vaccines), which carry with them an inevitable and sometimes unpredictable potential for harm. The following is a summary of some of the serious challenges facing pharmacovigilance programmes in the next ten years & the major challenges are:Globalization, Web-based sales and information, Broader safety concerns, Public health versus pharmaceutical industry economic growth , Monitoring of established products, Developing and emerging countries, Attitudes and perceptions to benefit and harm, Outcomes and Impact.

  • GASTROENTERITIS: NATURE AND PREVENTION

    ABOUT AUTHOR:
    Raj Kishor
    Avigna Clinical Research Institute
    Bangalore
    raryan859@gmail.com

  • CERVICAL CANCER VACCINE- A REVIEW

    ABOUT AUTHOR:
    Mamta Yadav
    M.Pharm
    Sagar Institute of Research Technical And Science-pharmacy
    Bhopal (M.P)
    mamtayadav811@gmail.com

  • BIPOLAR DISORDER – AN OVERVIEW

    About Authors:
    Dipal Patel*1, Dr. Kamal Singh Rathore1, Twinkal Patel2
    Department of Pharmacology
    1B.N. Institute of Pharmaceutical Science, Udaipur (Rajasthan), 313001
    2Shri Sarvajanik college of Pharmacy, Mehsana (Gujarat).
    *dipalpatel786@gmail.com

  • PHYTOTHERAPY OF CANCER - A BRIEF OVERVIEW

    About Author:
    Mridula Jayaraman,
    Amity Institute of Pharmacy,
    Amity University, India
    mridulajayaraman1990@gmail.com

    Abstract
    The word ‘cancer’ itself sends chills down our spines as its prognosis and treatment, even if detected at an early stage is cumbersome and tortuous. With the advent of modern medicines, even though it is claimed that cancer is curable, there exists virtually no chemotherapeutic agent for cancer without side effect(s), not to mention the cost of these medicines which are skyrocketing.
    Hence, we are left with little choice but to go for new fronts in research on the therapeutic agents present in plants (Phytotherapy), which are not only cost effective but also relatively side effects free.  These plants are available in plenty in the Himalayan and Aravali Region of India.  
    University
    of Wisconsin lists 150 plants which they have established as having potential value in the treatment of cancer.  However, the real issue here is that not many drugs derived from plants have been standardized and standardization of these plants for therapeutic purpose is still in the nascent stage.

  • CERVICAL CANCER A CURSE FOR GROWING AGE WOMEN: (A REVIEW)

    About Author:
    Shambhavi Singh
    M.pharma, Singhania University
    Jhunjhunu, Rajasthan
    Shambhavisingh6777@gmail.com

    Abstract
    Based on the figures from the World Health Organization, more than 20 lakhs women die worldwide because of cervical cancer per year. Cervical cancer, a potentially preventable disease, found as the second most common malignancy in women worldwide. In India, the disease accounts for a probable 24 percent of  India’s cancer cases among women and in addition to that 74,000 Indian women die annually from the disease, which results from the unusual growth of cells in the cervix. Cervical cancer is the most frequent disorder among women age near about 50 that increased the death rate  in  Indian rural women as compared urban due to lack awareness and don’t gain proper education. Cancer causing growth in the cervix is not a solitary type. It is not usually linked with hereditary genetic factor but a number of variable factors (Chemical, environmental and biological) indirectly enhance the risk of cervical cancer by increasing the possibility that a woman can contact an HPV infection. National Cancer Control Program emphasizes the significance of early detection and treatment. But our country has no well thought-out screening program and many women in India lack information regarding the disease and way to prevention and treatment facilities. Therefore, it is most of important to treat properly cervical cancer and make awareness in Indian women regarding its treatment and proper management.

    [adsense:336x280:8701650588]

  • REVIEW ON GOLD NANOPARTICLES FOR CANCER TREATMENT

    About Authors:
    M. B. Shinde*, S.V.Usnale1, M. B. Sorde2, O.V. Kolgire3
    Department of quality assurance,
    Maharashtra College Of Pharmacy, Nilanga.
    Dist- latur (MS)
    *maheshinde7@gmail.com

  • COMPARATIVE STATUS OF OXIDANT/ANTIOXIDANT IN PREGNANCY INDUCED HYPERTENSION AND CERVICAL DYSPLASIA

    About Author:
    *Seema Singh1, Sandeep Kumar Singh2
    1Department of Pharmacy, Northern India Engineering College, Lucknow (U.P.) India
    2Department of Pharmaceuticals Sciences, Dr. H S Guar University Sagar (M.P.), India
    *seema_b.pharm@rediffmail.com

    Abstract:
    Present study is aimed to delineate a co-relation between status of anti-oxidant enzymes, lipid peroxidation products with severity of Pregnancy Induced Hypertension (PIH) and cervical dysplasia. The study has been done on 66 patients out of whom 14 were normal pregnancy and had no disease, 31 patients of PIH and 21 patients having cervical dysplasia gr. I-II. Enzymatic activities of Superoxide dismutase (SOD), Catalase (CAT), vitamin C and vitamin E and malonaldehyde levels (MDA, a marker of lipid peroxides) were assessed spectrophotometrically. Mean Malonaldehyde level in PIH patients (8.48 ± 0.96) & Cervical patients (8.31 ± 1.25) in comparison to normal patients (4.88 ± 1.035), the rise was found highly significant (p < 0.001). The enzymatic activity of antioxidants such as Superoxide dismutase, Catalase, vitamin C and vitamin E was decreased in PIH patients & cervical dysplasia patients as compared to normal patients (p < 0.001). The difference was statistically significant (p < 0.001) whereas the same was observed in cervical dysplasia patients. No statistically difference was observed between the levels of antioxidants of PIH patients & cervical dysplasia patients (p < 0.01). Co-relation of Hb with MDA level showed that aneamic patients have raised level of MDA as compared to non aneamic patients. There is positive oxidant/antioxidant balance which may aggravate free radical damage during pre eclampsia and eclampsia with cervical dysplasia.

  • PERIPHERAL VASCULAR DISEASES: AN UNDERDIAGNOSED CAUSE OF PAIN

    ABOUT AUTHORS:
    Patil Reshma R.*, BhutkarM.A., Gaikwad Pranita T.
    Rajarambapu College of Pharmacy, Kasegaon,
    Maharashtra 415405 India
    *Patil.reshma1990@gmail.com

Subscribe to Pharmacology Articles